Turing Pharmaceuticals AG
www.turingpharma.com
Latest From Turing Pharmaceuticals AG
Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own
The Return Of The “Specialty” Drug Pricing Debate In The US
Pharma Tweeting: Five Twitter Moments That Highlight The Perils Of The Platform
Scrip takes a broad look at some controversial Twitter moments that pharma should be watchful of - words once let out of the cage cannot be whistled back again.
Drug Pricing And The Trump Effect: How To Make A High Profile Hearing Vanish
Without President Trump’s focus on drug pricing, it is hard to imagine that seven top industry executives would have had to face a grilling in the US Senate Finance Committee. But they can also thank Trump’s indiscretions for helping ensure that the hearing was barely even a one-day story.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Nasal
- Specialty Pharmaceuticals
-
Drug Delivery
- Therapeutic Areas
- Cardiovascular
- Gynecological, Urological
- Infectious & Viral Diseases
- Neurology, Nervous System
- Alias(es)
- Turing Pharmaceuticals LLC
- Turing Pharmaceuticals LLC
- Turing Pharmaceuticals LLC
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Switzerland
-
Switzerland
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Turing Pharmaceuticals AG
- Senior Management
-
Ron Tilles, Interim CEO
Nancy Retzlaff, Chief Commercial Officer
Eliseo Oreste Salinas, MD, Pres., R&D - Contact Info
-
Turing Pharmaceuticals AG
Phone: 41 760 24 24
Haldenstrasse 5
Baar, NY CH-6340
Switzerland
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice